CCMConcord Medical Services Holdings Ltd(CCM)Stock Analysis

AI analysis on 2,800+ stocks →
HealthcareNYSE
Institutional-grade research for retail investors
SEC EDGAR: CIK 1472072CCM stock profile & AI dashboard →

13F Pro Quality Score

Not in ranked universe

Limited institutional coverage

Quality rankings require at least 50 unique 13-F institutional holders to ensure peer comparisons are meaningful. Only 4 institutional filers currently hold this stock.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

CCM Stock Analysis & AI Quality Score

AI stock analysis and institutional research for Concord Medical Services Holdings Ltd (CCM), a Healthcare sector company. CCM is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least 50 unique 13-f institutional holders to ensure peer comparisons are meaningful. only 4 institutional filers currently hold this stock. Based on the latest XBRL financial filings (FY 2025), Concord Medical Services Holdings Ltd reports quarterly revenue of $65.9M, net income of $-13.3M, free cash flow of $-36.9M. Top institutional holders of CCM by reported 13-F value include SUSQUEHANNA INTERNATIONAL GROUP, LLP, UBS Group AG, MORGAN STANLEY, based on the most recent SEC filings. CCM trades on the NYSE exchange and files with the SEC under CIK 1472072. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CCM daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Concord Medical Services Holdings Ltd directly from SEC EDGAR.

Revenue

FY 2025

$65.9M

Net Income

FY 2025

$-13.3M

Free Cash Flow

FY 2025

$-36.9M

ROIC

FY 2025

-72.2%

Get alerted when CCM's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Concord Medical Services Holdings Ltd including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Top Institutional Holders of CCM

Put CCM on your watchlist

Track score changes the day Concord Medical Services Holdings Ltd files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is CCM a good stock to buy?

13F Pro's AI-powered analysis of Concord Medical Services Holdings Ltd (CCM) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for CCM are available on the CCM stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own CCM?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling CCM. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Concord Medical Services Holdings Ltd's investment landscape.